Bio-Engineering Institute
Dashboard Title: Manufacturing Projection and Total Purchases by Country Income Level Classification
Subtitle: Analyzing the impact of COVID-19 Vaccines on Manufacturing and Purchases
Overall Summary: This dashboard provides an in-depth analysis of the impact of the top 8 COVID-19 vaccines on the manufacturing and total purchases of each vaccine by country income level classification. It offers insights into the manufacturing projection for 2021 and 2022, and the total purchases of each vaccine by country income level.
Dashboard Insights:
Analyze the manufacturing projection of the top 8 COVID-19 vaccines in 2021 and 2022
Compare the manufacturing projection of each vaccine between 2021 and 2022
Understand the total purchases of each vaccine by country income level
Who Can Benefit: This dashboard can be used by healthcare professionals, policy makers, and researchers to gain insights into the manufacturing projection and total purchases of each vaccine by country income level classification. This dashboard can help healthcare professionals and policy makers to make informed decisions on the distribution of vaccines and resources. Researchers can use this dashboard to analyze the impact of the top 8 COVID-19 vaccines on the manufacturing and total purchases of each vaccine by country income level classification.
Who Can Use:
Healthcare Professionals
Policy Makers
Researchers
Benefits:
Insight into the manufacturing projection of the top 8 COVID-19 vaccines in 2021 and 2022
Ability to compare the manufacturing projection of each vaccine between 2021 and 2022
Understand the total purchases of each vaccine by country income level
Informed decisions on the distribution of vaccines and resources
Analysis of the impact of the top 8 COVID-19 vaccines on the manufacturing and total purchases of each vaccine by country income level classification.
Tab 1.1 Manufacturing Projection (2021 & 2022) and total Tab 1.2 Manufacturing Projection 2021 vs 2022
purchases by country income level classification
Manufacturing Projection (2021 & 2022) and Total Purchases by Country Income Level
Classification
RNA
Moderna
Pfizer-BioNTech
Arcturus Therapeutics
(ARCT-021)
Providence
(PTX-COVID19-B)
Inactivated Valneva (VLA2001)
Bharat Biotech
(Covaxin)
Sinovac (Coronavac)
Sinopharm-Beijing